Hepatitis C Reflex Testing
The 2023 amendment to the New York State Testing Law requires if the hepatitis C screening test is reactive, a hepatitis C ribonucleic acid test (RNA) must be performed on the same specimen, or a second specimen collected at the same time as the initial hepatitis C screening test specimen, to confirm diagnosis of current infection. This is also referred to as reflex testing. This amendment is to ensure complete and timely diagnosis of HCV. If the subsequent HCV RNA test is negative, HCV infection is effectively ruled out for most patients. If the reflex HCV RNA test is positive, a diagnosis of active HCV infection has been confirmed, and the individual should be referred directly for HCV care and treatment.
Reflex testing obviates the need for the patient to return for follow-up testing should the initially HCV antibody test be reactive. If the RNA test is negative, the work-up is done, and the patient may be reassured.
- Hepatitis C Testing Law
- APHL Guidance on Hepatitis C Reflex Testing
- CDC Guidance on HCV Reflex Testing, July 13, 2023
- HCV Reflex Testing Dear Colleague Letter: The purpose of this letter is to provide information to all clinicians and lab directors on HCV reflex testing as a method for ensuring timely HCV diagnosis and linkage to care.
- Validating HCV Quantitative assays for reflex testing - NYSDOH CLEP guidance to labs
- NYSDOH Medicaid reimbursement of reflex testing
- CDC Hepatitis C Testing Guidance for Clinicians and Laboratories
- CDC testing algorithm
- CDC lab interpretation table